Article Text

SP0137 Mirs in Activation of Myeloid Cells in RA
  1. M. Kurowska-Stolarska
  1. Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom


The development of new treatments for rheumatoid arthritis (RA) is limited by our incomplete understanding of disease pathogenesis. Particularly, those pathways mediating disease onset, failed repair, and the development of treatment-refractory states are poorly understood. Myeloid cells (including dendritic cells, monocytes, macrophages) likely participate in such processes in RA. We recently discovered a novel epigenetic control mechanism of myeloid cells mediated via microRNA (miR) and obtained evidence for deregulation of this process in RA. We hypothesised that microRNAs controls transcriptional responses to growth and environmental factors of mononuclear myeloid cell subtypes and that its disregulation can contribute to the cause and perpetuation of arthritis.

Disclosure of Interest None declared

DOI 10.1136/annrheumdis-2014-eular.6295

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.